Willmott Dixon completes Southampton healthcare R&D facilities

Willmott Dixon has announced the completion of two healthcare R&D facilities in Southampton.

Adanac Health and Innovation Campus (c) Adanac

Adanac Health and Innovation Campus (c) Adanac

Partnering with Prime, Macquarie Group and IHSS, the company has completed an aseptic pharmacy and sterile services department (SSD) at the Adanac Health and Innovation Campus.

The aseptic pharmacy will manufacture sterile medicines for University Hospital Southampton (UHS) and other NHS providers in the region, while the SSD will sterilise medical devices and equipment.

Richard Poulter, managing director at Willmott Dixon in the South, said: ‘We are proud to have played a key role in delivering these state-of-the-art healthcare facilities at Adanac Health and Innovation Campus.

‘This project showcases the power of collaboration in addressing the evolving needs of the NHS and the wider healthcare sector. By combining innovative design, specialist expertise, and a strong sustainability focus, we have created a facility that will make a lasting impact on patient care and medical services across the region.'

The innovation we cannot afford to miss

The innovation we cannot afford to miss

10 July 2026

Kimberley Frost, lead for Women in Health Innovation & Technology and workstream lead for the deputy chief executives office, Health Innovation Yorkshire & H...

Waiting list rises for second month amid record A&E attendances

By Lee Peart 09 July 2026

The overall NHS waiting list rose for the second consecutive month in May, up by 60,153 on April, to 7.28m.

Government announces £85m AI anti-obesity programme

By Lee Peart 29 June 2026

People with obesity are to be given new ways of accessing support through a new £85m AI programme.


Popular articles by Lee Peart